BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11985558)

  • 1. Flow cytometric analysis of platelet activation under calcium ion-chelating conditions.
    Nishioka T; Yokota M; Tsuda I; Tatsumi N
    Clin Lab Haematol; 2002 Apr; 24(2):115-9. PubMed ID: 11985558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis.
    Schrezenmeier H; Müller H; Gunsilius E; Heimpel H; Seifried E
    Thromb Haemost; 1995 Mar; 73(3):506-13. PubMed ID: 7545322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDTA-dependent pseudothrombocytopenia in a child.
    Akbayram S; Dogan M; Akgun C; Caksen H; Oner AF
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):494-6. PubMed ID: 20530050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy.
    Ahnadi CE; Sabrinah Chapman E; Lépine M; Okrongly D; Pujol-Moix N; Hernández A; Boughrassa F; Grant AM
    Thromb Haemost; 2003 Nov; 90(5):940-8. PubMed ID: 14597991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of platelet aggregation in six cases of EDTA-dependent pseudothrombocytopenia].
    Shimasaki A; Kato T; Ozaki Y
    Rinsho Ketsueki; 1994 Jun; 35(6):529-34. PubMed ID: 8078186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia.
    Bartels PC; Schoorl M; Lombarts AJ
    Scand J Clin Lab Invest; 1997 Nov; 57(7):629-36. PubMed ID: 9397495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin can be added to blood to reduce the fall in platelet count.
    Zhou X; Wu X; Deng W; Li J; Luo W
    Am J Clin Pathol; 2011 Oct; 136(4):646-52. PubMed ID: 21917689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The platelet count in EDTA-anticoagulated blood from patients with thrombocytopenia may be underestimated when measured in routine laboratories.
    Podda GM; Pugliano M; Femia EA; Mezzasoma AM; Gresele P; Carpani G; Cattaneo M
    Am J Hematol; 2012 Jul; 87(7):727-8. PubMed ID: 22674424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of theophylline in the investigation of pseudothrombocytopenia induced by edetic acid (EDTA-2K).
    Ohnuma O; Shirata Y; Miyazawa K
    J Clin Pathol; 1988 Aug; 41(8):915-7. PubMed ID: 3139717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system.
    Macey M; Azam U; McCarthy D; Webb L; Chapman ES; Okrongly D; Zelmanovic D; Newland A
    Clin Chem; 2002 Jun; 48(6 Pt 1):891-9. PubMed ID: 12029005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The routine measurement of platelet size using sodium citrate alone as the anticoagulant.
    Bath PM
    Thromb Haemost; 1993 Oct; 70(4):687-90. PubMed ID: 8115997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic subdural hematoma in elderly patient with EDTA-dependent pseudothrombocytopenia recently treated with aspirin and warfarin: case report.
    Tosa M; Fujita H; Ishihama Y; Nishimura S; Ide T
    Neurol Med Chir (Tokyo); 2014; 54(5):401-4. PubMed ID: 24477063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium citrate, low molecular weight heparin, and prostaglandin E1 on aggregation, fibrinogen binding, and enumeration of equine platelets.
    Kingston JK; Bayly WM; Sellon DC; Meyers KM; Wardrop KJ
    Am J Vet Res; 2001 Apr; 62(4):547-54. PubMed ID: 11327462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis.
    Lombarts AJ; de Kieviet W
    Am J Clin Pathol; 1988 May; 89(5):634-9. PubMed ID: 3128946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EDTA-induced platelet aggregation can be avoided by a new anticoagulant also suitable for automated complete blood count.
    Lippi U; Schinella M; Nicoli M; Modena N; Lippi G
    Haematologica; 1990; 75(1):38-41. PubMed ID: 2110927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Amikacin on Pseudothrombocytopenia.
    Bokaei PB; Grabovsky D; Shehata N; Wang C
    Acta Haematol; 2017; 137(1):27-29. PubMed ID: 27852074
    [No Abstract]   [Full Text] [Related]  

  • 18. EDTA-dependent pseudothrombocytopenia confirmed by supplementation of kanamycin; a case report.
    Ahn HL; Jo YI; Choi YS; Lee JY; Lee HW; Kim SR; Sim J; Lee W; Jin CJ
    Korean J Intern Med; 2002 Mar; 17(1):65-8. PubMed ID: 12014216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt.
    Schuff-Werner P; Steiner M; Fenger S; Gross HJ; Bierlich A; Dreissiger K; Mannuß S; Siegert G; Bachem M; Kohlschein P
    Br J Haematol; 2013 Sep; 162(5):684-92. PubMed ID: 23808903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean platelet volume measurement, EDTA or citrate?
    Dastjerdi MS; Emami T; Najafian A; Amini M
    Hematology; 2006 Oct; 11(5):317-9. PubMed ID: 17607580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.